← FDA Drug Approvals (Drugs@FDA)

AMPICILLIN AND SULBACTAM

ANDA · Abbreviated New Drug Application (Generic) · Sponsor: HIKMA · Approved 2002-03-19

Drug application

FDA Application #

ANDA065076

Application type

Abbreviated New Drug Application (Generic)

Brand name

AMPICILLIN AND SULBACTAM

Generic name

Ampicillin Sodium

Active ingredients

AMPICILLIN SODIUM; SULBACTAM SODIUM

Dosage form

INJECTABLE

Route

INJECTION

Marketing status

Prescription

Sponsor

HIKMA

First approval

2002-03-19

Source

Authoritative

Drugs@FDA application overview

Machine

JSON-LD · Markdown